Compare Bristol-Myers Squibb Co (BMY) vs Fox Corp Class A (FOXA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Fox Corp Class A — how do they compare? Bristol-Myers Squibb Co trades at $63.7 (market cap $129.94B), while Fox Corp Class A trades at $61.87 (market cap $24.58B). The key difference: Bristol-Myers Squibb Co is far larger — about 5.3× Fox Corp Class A's market cap, and Bristol-Myers Squibb Co pays the higher dividend (3.96%). Which is the better fit depends on your goals.
| BMY | FOXA | |
|---|---|---|
Market Cap | $129.94B | $24.58B |
Sector | Health | Media |
52-Week High | $65.89 | $76.11 |
52-Week Low | $42.60 | $48.79 |
Enterprise Value | $163.92B | $27.94B |
Dividend Yield | 3.96% | 0.93% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Fox Corp Class A
Fox operates in cable networks and television. Its cable segment includes Fox News, Fox Business, and sports channels, while its TV segment covers the Fox network, 29 local stations (18 Fox-affiliated), and the ad-supported streaming service Tubi. After selling most of its entertainment assets to Disney in 2019, Fox now focuses on live news and sports, primarily within pay-TV. The Murdoch family controls the company.
Read more on FOXA →
